Rivastigmine in Mild Alzheimer's Disease, FMRI Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of the study is to investigate the effect of rivastigmine given as an acute dose compared to placebo and after 1 month chronic dosing on fMRI response during a face recognition task. Furthermore, the aim is to investigate whether fMRI response is correlated with long term treatment effect at 6 months and 12 months.
Epistemonikos ID: 418532b269529d87c3cb89f2201fd30f19c9f4dd
First added on: May 04, 2024